Caris Life Sciences (CAI) Gross Profit (2024 - 2026)
Caris Life Sciences (CAI) posted quarterly Gross Profit of $214.2 million for Q1 2026, up 256.93% year-over-year from $60.0 million in Q1 2025, and up 460.36% quarter-over-quarter from $38.2 million in Q4 2025.
Caris Life Sciences (CAI) Gross Profit (2024 - 2026) Analysis & Trends
Caris Life Sciences' Gross Profit history runs 3 years deep, the most recent figure standing at $214.2 million for Q1 2026.
- In Q1 2026, Gross Profit rose 256.93% year-over-year to $214.2 million; the TTM figure through Mar 2026 stood at $518.4 million (up 56.87% YoY), while the FY2025 annual figure was $549.7 million, up 36.78% from the prior year.
- Gross Profit for Q1 2026 stood at $214.2 million, up from $38.2 million in the prior quarter.
- The five-year high for Gross Profit was $214.2 million in Q1 2026, with the low at $38.2 million in Q4 2025.
- The 3-year median for Gross Profit is $106.5 million (2024), against an average of $106.1 million.
- The sharpest annual moves came in 2025 and 2026: Gross Profit slumped 69.81% in 2025, then jumped 256.93% in 2026.
- Caris Life Sciences' Gross Profit stood at $126.6 million in 2024, then plunged by 69.81% to $38.2 million in 2025, then surged by 460.36% to $214.2 million in 2026.
- Business Quant data shows CAI's Gross Profit at $214.2 million in Q1 2026, $38.2 million in Q4 2025, and $149.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Caris Life Sciences | 6.16 Bn | 5.37 Bn | 182.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 182.38 Mn |
| Jun 30, 2026 | 182.38 Mn |
| Mar 31, 2026 | 214.23 Mn |
| Mar 31, 2026 | 214.23 Mn |
| Dec 31, 2025 | 38.23 Mn |
| Dec 31, 2025 | 38.23 Mn |
| Sep 30, 2025 | 149.85 Mn |
| Sep 30, 2025 | 149.85 Mn |
| Jun 30, 2025 | 116.08 Mn |
| Jun 30, 2025 | 116.08 Mn |
| Mar 31, 2025 | 60.02 Mn |
| Mar 31, 2025 | 60.02 Mn |
| Dec 31, 2024 | 126.64 Mn |
| Dec 31, 2024 | 126.64 Mn |
| Sep 30, 2024 | 46.81 Mn |
| Sep 30, 2024 | 46.81 Mn |
| Jun 30, 2024 | 96.99 Mn |
| Jun 30, 2024 | 96.99 Mn |